1-3 of 3
O. O’Connor
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Histone Deacetylase Inhibitors Demonstrate Significant Preclinical Activity as Single Agents, and in Combination with Bortezomib in Waldenstrom's Macroglobulinemia.

Jenny Sun, MD, Lian Xu, Hsiuyi Tseng, Bryan Ciccarelli, Mariateresa Fulciniti, Zachary Hunter, Kaveh Maghsoudi, Evdoxia Hatjiharissi, MD, Yangsheng Zhou, MD, PhD, Guang Yang, PhD, B. Zhu, Xia Liu, Ping Gong, Thea Ioakimidis, MS, Patricia Sheehy, NP, Robert Manning, Christina Hanzis, Megan Lewicki, Christopher J Patterson, Dharminder Chauhan, Ph.D, Scott J. Rodig, MD, PhD, Nikhil C. Munshi, Kenneth. C Anderson, MD, Owen O O'Connor, MD, Steven Treon, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 4785.
https://doi.org/10.1182/blood.V114.22.4785.4785
Published: 2009
Journal Articles

Phase 1 Study of ABT-263, a Bcl-2 Family Inhibitor, in Relapsed or Refractory Lymphoid Malignancies.

Wyndham H Wilson, MD, PhD, O. O’Connor, M.D., Myron S. Czuczman, MD, Ann LaCasce, MD, J. Gerecitano, M.D., Ph.D., John P. Leonard, MD, Anil Tulpule, MD, Hao Xiong, Ph.D., Yi-Lin Chiu, Ph.D., Todd Busman, Ph.D., Raymond A. Knight, MBA, Sari Enschede, M.D., Andrew Krivoshik, M.D., Ph.D., Rod Humerickhouse, M.D., Ph.D
Journal: Blood
Blood (2008) 112 (11): 2108.
https://doi.org/10.1182/blood.V112.11.2108.2108
Published: 2008
Journal Articles

A Phase I/II Trial of the Kinesin Spindle Protein (KSP) Inhibitor SB- 743921 Administered on Days 1 and 15 Every 28 Days without and with Prophylactic G-CSF in Non-Hodgkin or Hodgkin Lymphoma.

John Gerecitano, O. O’Connor, H. Van Deventer, J. Hainsworth, J. Leonard, A. Goy, B. Afanasyev, M. Chen, K. Saikali, M. G Conlan, R Escandon, A Wolff
Journal: Blood
Blood (2008) 112 (11): 1563.
https://doi.org/10.1182/blood.V112.11.1563.1563
Published: 2008